The company maintains a strong liquidity position, with cash and equivalents amounting to 4,594,824,000 JPY, representing a significant portion of its total assets. The liquidity FPT (free cash flo…
The company maintains a strong liquidity position, with a current ratio of 7.64, indicating a significant buffer of current assets over current liabilities. Its cash and equivalents amount to 2,823…
The company's capital structure is characterized by a high proportion of equity, with total equity of CNY 995.23 million and total liabilities of CNY 49.24 million, resulting in a debt-to-equity ra…
The company's capital structure is characterized by a high price-to-book ratio of 5.06, indicating that the market values the company significantly above its book value. However, the negative opera…
ALIMP.PA exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 14.66, indicating a significant reliance on debt financing. The company's liquidity position is weak, as evide…
MKDWELL Tech Inc has a negative equity position of -$95.46 million and a debt-to-equity ratio of -1.15, indicating a leveraged capital structure with significant long-term debt of $109.59 million.…
Compumedics has a basic and diluted share count of 199,761,754, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be assessed due to the absence of ba…
Structure and Liquidity Essilorluxottica has a basic and diluted share count of 463,190,305 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertibl…
Structure and Liquidity HOOK Inc. maintains a strong liquidity position with $39.68 million in cash and equivalents, representing 48.1% of total assets. The company has no long-term debt, resulting…
IBTB.ST exhibits a weak capital structure and liquidity position, as evidenced by a negative return on equity of -61.87% and a negative return on assets of -40.29%. The company has no long-term deb…
Jenburkt Pharmaceuticals Ltd has a capital structure with 4,413,300 basic and diluted shares outstanding, indicating no dilution from potential share issuance. However, liquidity risk could not be…
Odonate Inc has a capital structure characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations, and a current ratio of 5.91, suggesting strong short-term liquidity. Th…
The company's capital structure shows a debt-to-equity ratio of 0.28, indicating a relatively conservative leverage position. However, the negative net income of CNY -732.14 million and a free cash…
Daan Gene Co Ltd has a total equity of CNY 7.14 billion and a total debt of CNY 179.41 million, resulting in a debt-to-equity ratio of 0.03, which is significantly lower than the industry median. T…
The company maintains a strong liquidity position, with a current ratio of 2.57, indicating that it has more than twice the current assets to cover its current liabilities. However, its liquidity r…
The company maintains a relatively strong liquidity position, with cash and equivalents amounting to KRW 26.75 billion, which is 44.3% of its total liabilities. However, its net cash position is ne…
Mediana Co Ltd maintains a strong liquidity position, with a current ratio of 10.69 and cash and equivalents of 26,939,138,430 KRW, indicating robust short-term financial flexibility. The company's…
Rici Healthcare's capital structure is characterized by a debt-to-equity ratio of 1.22, indicating a moderate reliance on debt financing. The company holds CNY 1.14 billion in cash and equivalents,…
As Partners Co Ltd maintains a liquidity position with a current ratio of 1.24, indicating a moderate ability to meet short-term obligations, supported by cash and equivalents of 5,707,562,000 JPY.…
KeyMed Biosciences Inc has a market capitalization of 18.07 billion CNY, with a current market price of 60.5 CNY per share. The company's shares outstanding are 298.74 million, with no dilution obs…
The company's capital structure is characterized by a debt-to-equity ratio of 0.35, indicating a relatively conservative leverage position. However, the company's liquidity is assessed as medium, w…
Saint Bella Group Ltd has a market capitalization of 2,457,676,175 CNY, with a current market price of 3.95 CNY per share. The company has 622,196,500 basic and diluted shares outstanding, indicati…
AnGes Inc maintains a strong liquidity position with a current ratio of 1.86 and a price-to-book ratio of 0.76, indicating that the company's market value is below its book value. The company holds…
GuangYuYuan Chinese Herbal Medicine Co Ltd maintains a strong liquidity position, with a current ratio of 2.15, indicating the company can cover its short-term liabilities with its short-term asset…
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥2,491,423,000, significantly exceeding its total liabilities of ¥1,926,647,000, resulting in a current rat…
Structure and Liquidity Hcmed Innovations Co Ltd has a basic and diluted share count of 32,717,000 shares outstanding, indicating no dilution from potential share issuance. However, liquidity risk…
The company's capital structure is characterized by a high debt-to-equity ratio of 3.96, indicating a significant reliance on debt financing. Its liquidity position is assessed as medium, with a cu…
The company maintains a strong liquidity position, with a current ratio of 2.04 and cash and equivalents amounting to ¥3.58 billion. However, the company reported negative free cash flow of ¥1.95 b…
The company's capital structure is characterized by a lack of detailed balance-sheet inputs, which prevents a comprehensive assessment of its liquidity position. The shares outstanding for both bas…
Nfl Biosciences SAS has a fully diluted share count of 12,672,242 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or converti…
Structure and Liquidity Enzymatica maintains a strong liquidity position with SEK 33.13 million in cash and equivalents, representing 22.6% of total assets. The company's price-to-book ratio of 5.5…
IMD's capital structure is characterized by a lack of dilution risk, as shares outstanding remain unchanged between basic and diluted counts at 17,321,175. However, liquidity risk could not be asse…
JPHM.AM maintains a debt-to-equity ratio of 0.67, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium, with a current ra…
The company's capital structure is marked by a debt-to-equity ratio of 1.13, indicating a moderate reliance on debt financing. Liquidity is constrained, with a current ratio of 0.74, suggesting the…
LIVI.SI maintains a liquidity position with a current ratio of 1.02, indicating a balanced short-term liquidity profile, though it is not significantly above the threshold of 1.0. The company's cas…
Mabion SA maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.3, indicating a low reliance on debt financing. The company holds PLN 47.8 million in cash and equi…
The company's capital structure and liquidity position cannot be assessed due to the absence of financial snapshot data and relevant source documents. Without access to liquidity metrics or valuati…
New Horizon Health Ltd exhibits a capital structure with a debt-to-equity ratio of 0.12, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized by…
Sinsin Pharmaceutical Co Ltd maintains a debt-to-equity ratio of 0.58, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio…
Standard Chem & Pharm Co Ltd maintains a relatively strong liquidity position, with a current ratio of 1.91 and cash and equivalents amounting to TWD 1,023,124,000. However, the company's net cash…
The company maintains a strong liquidity position, with a current ratio of 5.9, indicating a significant buffer of current assets over current liabilities. The absence of long-term debt and a debt-…
Mirqes operates with a fully diluted share count of 298.23 million shares, matching its basic share count, indicating no dilution from stock options or convertible instruments. The company has not…
Chongqing Lummy Pharmaceutical Co Ltd has a relatively strong liquidity position, with a current ratio of 2.55, indicating that it has more than twice as many current assets as current liabilities.…
Katakura Industries maintains a strong liquidity position, with cash and equivalents amounting to ¥31.49 billion, representing 20.6% of total assets. The company's liquidity FPT (free cash flow to…
Staidson (Beijing) BioPharmaceuticals Co Ltd has a current liquidity position that is characterized by a negative net cash position after subtracting total debt, indicating potential liquidity risk…
Hokuyaku Takeyama Holdings Inc maintains a strong liquidity position, with cash and equivalents amounting to ¥20.813 billion, representing 14.13% of total assets. The company's liquidity FPT (free…
Genetics Generation Advancement Corp maintains a strong liquidity position, with a current ratio of 3.62, indicating the company can easily cover its short-term liabilities with its short-term asse…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative approach to financing, with a strong equity base of 419,176,000 TWD and total liabi…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.13, indicating a conservative approach to leverage. With cash and equivalents amounting to 106,846,000 TWD, the c…
Vcanbio Cell & Gene Engineering Corp Ltd maintains a strong liquidity position, with a current ratio of 1.82, indicating the company can cover its short-term liabilities with its short-term assets.…
Nanjing Pharmaceutical Group Co Ltd has a market price of 5.03 CNY per share, with a market capitalization of 6.58 billion CNY. The company's price-to-earnings ratio is 10.54, and its price-to-book…
6569.TWO has a market capitalization of 3.77 billion TWD and a price-to-earnings ratio of 33.62, indicating a relatively high valuation compared to its earnings. The company's price-to-book ratio i…
The company maintains a liquidity position with a current ratio of 2.32, indicating a strong ability to meet short-term obligations, supported by cash and equivalents of 172,584 million JPY. Howeve…
The company maintains a debt-to-equity ratio of 0.84, indicating a moderate reliance on debt financing, and a current ratio of 1.24, suggesting it has sufficient short-term assets to cover its shor…
ShareHope Medicine Co Ltd maintains a debt-to-equity ratio of 0.58, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium…
Nicox SA has a total revenue of €1.8 million, with 88.13 million shares outstanding, both basic and diluted, indicating no immediate dilution pressure from share issuance. However, liquidity risk c…
The company maintains a conservative capital structure with a debt-to-equity ratio of 0.2, indicating limited leverage relative to its equity base. Total assets stand at $43.98 million, supported b…
Thonburi Medical Centre PCL maintains a strong liquidity position, with a current ratio of 4.43 and cash and equivalents amounting to 249.35 million THB, indicating a robust ability to meet short-t…
KMDA.KL's capital structure is characterized by a relatively low debt-to-equity ratio of 0.22, indicating a conservative leverage position compared to industry norms. The company's liquidity is ass…
LKMNH.IS has a debt-to-equity ratio of 0.6, indicating a relatively balanced capital structure with a moderate reliance on debt financing. The company's liquidity position is assessed as medium, wi…
M-CHAI.BK has a liquidity position that is relatively constrained, as evidenced by a current ratio of 0.5, indicating that the company's current liabilities significantly exceed its current assets.…
Ilyang Pharmaceutical maintains a conservative capital structure with a debt-to-equity ratio of 0.4, indicating a relatively low reliance on debt financing. The company's liquidity position is asse…
The company maintains a relatively strong liquidity position, with cash and equivalents amounting to KRW 9,947.5 million, which is sufficient to cover its long-term debt of KRW 17,391.8 million by…
The company's capital structure is characterized by a debt-to-equity ratio of 0.94, indicating a relatively balanced mix of debt and equity financing. Despite a current ratio of 0.57, which suggest…
EyeGene Inc maintains a strong liquidity position with a current ratio of 8.53, indicating the company can easily cover its short-term liabilities with its current assets. The company holds KRW 5,9…
Chaoju Eye Care's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in source documents.…
Vital Ksk Holdings Inc maintains a strong liquidity position with a current ratio of 1.07 and cash and equivalents amounting to 23,099,000,000 JPY. The company's debt-to-equity ratio is 0.08, indic…
Abnova Taiwan Corp maintains a strong liquidity position, with a current ratio of 9.31, indicating that the company has significantly more current assets than current liabilities. The company's cas…
PhoenixBio maintains a strong liquidity position with cash and equivalents amounting to ¥1.385 billion, which is significantly higher than its total liabilities of ¥917.713 million, resulting in a…
Toshiba maintains a capital structure with a debt-to-equity ratio of 0.6, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1…
The company maintains a balanced capital structure with a debt-to-equity ratio of 0.42, indicating a moderate reliance on debt financing. Its liquidity position is characterized by a current ratio…
The company maintains a conservative capital structure with a debt-to-equity ratio of 0.42, indicating a relatively low reliance on debt financing. Its liquidity position is characterized by a curr…
ASIM.SI's capital structure is characterized by a debt-to-equity ratio of 1.11, indicating a moderate level of leverage. The company holds cash and equivalents of SGD 5,694,450, but its long-term d…
CARE.KL's capital structure is characterized by a relatively low debt-to-equity ratio of 0.15, indicating a conservative approach to financing. However, the company's liquidity position is rated as…
Connect Biopharma has a market capitalization of $156.15 million, with a current market price of $2.48 per share. The company has no dilution risk in the near term, as the number of basic and dilut…
EUKE.MI's capital structure is characterized by a high debt-to-equity ratio of 4.17, indicating a significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a…
ImmuCell Corp has a market capitalization of $76.63 million and a price-to-book ratio of 2.83, indicating a premium valuation relative to its book value. The company's liquidity position is charact…
Madrigal Pharmaceuticals Inc (MDGL.O) is currently classified as Commercial Banks within Banks (Financials). Classification confidence: 0.66 (rule-based classification). Capital structure on the la…
MKDWELL Tech Inc operates with a negative equity position of $3.47 million and a debt-to-equity ratio of -1.26, indicating a capital structure heavily reliant on debt financing. The company's liqui…
The company's capital structure is highly leveraged, with total liabilities of 781,650 AUD and total equity of -268,370 AUD, resulting in a negative debt-to-equity ratio of -1.53. Liquidity is cons…
Principal Capital PCL exhibits a capital structure with a debt-to-equity ratio of 0.48, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, wit…
PROCF.PK's capital structure is highly leveraged, with total liabilities of $462.8 million and total equity of -$51.1 million, resulting in a debt-to-equity ratio of -6.0. The company's liquidity p…
Uniholdings Inc has a debt-to-equity ratio of 1.55, indicating a significant reliance on debt financing, and a current ratio of 0.17, suggesting limited short-term liquidity to cover immediate liab…
Vitasora Health Ltd has a market capitalization of approximately 19.4 million AUD, with a market price of 0.01 AUD per share, indicating a very low valuation in the market. The company has a total…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative leverage position. With total equity of 277.73 million HKD and total liabilities of…
The company's capital structure is characterized by a debt-to-equity ratio of 0.24, indicating a relatively low level of leverage compared to the industry median. The liquidity position is marked b…
Essex Bio-Technology Ltd maintains a strong liquidity position, with a current ratio of 2.11 and cash and equivalents amounting to HKD 782.73 million, indicating a solid ability to meet short-term…
Sirnaomics has a market capitalization of USD 663.8 million, with a market price of USD 6.05 per share. The company has 109.7 million shares outstanding, with no dilution from potential share issua…
The company's capital structure is characterized by a strong liquidity position, with a current ratio of 4.0, indicating a robust ability to meet short-term obligations. The company's market price…
TYK Medicines Inc exhibits a highly leveraged capital structure, with total liabilities of CNY 1.54 billion and total equity of -CNY 938.86 million, resulting in a negative debt-to-equity ratio of…
Nanjing Hicin Pharmaceutical Co Ltd has a debt-to-equity ratio of 0.27, indicating a relatively conservative capital structure with limited leverage. The company's liquidity position is characteriz…
Adimmune Corp's capital structure shows a debt-to-equity ratio of 0.57, indicating a moderate level of leverage. The company's liquidity position is characterized by a current ratio of 2.12, sugges…
Falco Holdings maintains a strong liquidity position, with cash and equivalents amounting to ¥9.42 billion, representing 26.15% of total assets. The company's liquidity FPT (free cash flow to total…
The company's capital structure is characterized by a debt-to-equity ratio of 0.69, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
Excelsior Biopharma Inc has a market price of 23.55 TWD per share and a market capitalization of 1,096,911,900 TWD, with a price-to-book ratio of 1.03 and a price-to-tangible-book ratio of 1.03. Th…
BDX.AX has a current ratio of 2.32, indicating a moderate level of liquidity, but its operating cash flow of -6,135,890 AUD and free cash flow of -7,026,760 AUD suggest significant cash outflows. T…
COMF.KL's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative leverage position. The company's liquidity is assessed as medium, with a current ratio…
LHCL.CM maintains a strong liquidity position, with a current ratio of 4.13, indicating the company has sufficient current assets to cover its current liabilities multiple times over. The company's…
The company's capital structure is characterized by a debt-to-equity ratio of 0.99, indicating a relatively balanced mix of debt and equity financing. However, its liquidity position is constrained…
RWB.CD has a negative equity position of -240,968,000 CAD, indicating a significant debt burden relative to its equity base. The company's liquidity position is further strained by a cash and equiv…
The company maintains a strong liquidity position, with a current ratio of 5.65, indicating a robust ability to meet short-term obligations. Its liquidity_fpt score suggests that the firm is not un…
Pak Fah Yeow International Ltd has a market capitalization of 757,285,200 HKD, with a market price of 2.43 HKD per share. The company's capital structure is characterized by a lack of dilution risk…
Metabiomed maintains a capital structure with a debt-to-equity ratio of 0.86, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a c…
The company's capital structure is characterized by a debt-to-equity ratio of 0.73, indicating a moderate reliance on debt financing. However, its liquidity position is weak, with only 250 KRW in c…
The company's capital structure is characterized by a debt-to-equity ratio of 0.98, indicating a relatively balanced mix of debt and equity financing. However, the company's liquidity position is c…
PW Medtech Group Ltd maintains a strong liquidity position, with cash and equivalents amounting to CNY 1.8 billion, representing 34.4% of total assets. The company's liquidity FPT (free cash flow t…
SciVision Biotech Inc maintains a strong liquidity position, with a current ratio of 3.16 and cash and equivalents amounting to 554.61 million TWD, which is well above the industry median for liqui…
Nippon Care Supply maintains a conservative capital structure with a debt-to-equity ratio of 0.19, significantly below the industry median of 0.45, indicating a low reliance on debt financing. The…
DongKook Life Science maintains a capital structure with a basic and diluted share count of 31,984,140 shares, indicating no immediate dilution pressure from share-based compensation or convertible…
Win-Partners Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to ¥16,209,529,000, representing 34.8% of total assets. The company has no long-term debt, and its deb…
Intai Technology Corp maintains a debt-to-equity ratio of 0.53, indicating a moderate reliance on debt financing, while its current ratio of 2.13 suggests reasonable short-term liquidity. The compa…
The company maintains a strong liquidity position, with a current ratio of 11.49, indicating a significant buffer of current assets over current liabilities. Its cash and equivalents amount to 456,…
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥10,625,818,000, which significantly exceeds its total liabilities of ¥6,160,428,000. The current ratio of…
The company maintains a strong liquidity position, with a current ratio of 3.12, indicating that it has more than three times the current assets to cover its current liabilities. Its cash and equiv…
ABT.HM maintains a strong capital structure with a debt-to-equity ratio of 0.2, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized by a curren…
Ainos Inc has a market capitalization of $12.72 million and a price-to-book ratio of 1.68, indicating that the market values the company at a premium to its book value. The company's liquidity posi…
ALKLH.PA maintains a conservative capital structure with a debt-to-equity ratio of 0.19, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium, wi…
ALVIO.PA exhibits a highly leveraged capital structure, with total liabilities of EUR 26.86 billion and total equity of EUR -8.93 billion, resulting in a negative debt-to-equity ratio of -0.9. The…
Aneb operates with a highly liquid capital structure, as evidenced by a current ratio of 24.53, indicating strong short-term liquidity. The company has no long-term debt and a debt-to-equity ratio…
BIOQ.PK maintains a strong liquidity position with $17.85 million in cash and equivalents, representing 31.2% of total assets, and a current ratio of 3.72, indicating robust short-term financial he…
BSEM.PK's capital structure is characterized by a low debt-to-equity ratio of 0.08, indicating a conservative leverage profile. The company maintains a strong liquidity position with a current rati…
Cypherpunk Technologies Inc maintains a strong liquidity position, with a current ratio of 35.56, indicating a significant buffer of current assets over current liabilities. The company's cash and…
Rapid Dose Therapeutics Corp has a negative equity position of -3,157,950 CAD and a debt-to-equity ratio of -0.71, indicating a significant reliance on debt financing and a weak capital structure.…
The company maintains a conservative capital structure with zero debt, resulting in a debt-to-equity ratio of 0.0. Total equity stands at $233.1 million, supported by cash and equivalents of $129.9…
Nova Leap Health Corp maintains a relatively strong liquidity position, with a current ratio of 1.78, indicating the company can cover its short-term liabilities with its short-term assets. The com…
Ondine Biomedical Inc has a capital structure with 519,551,468 basic and diluted shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instrumen…
The company maintains a debt-to-equity ratio of 0.5, indicating a relatively balanced capital structure with a moderate reliance on debt financing. Its liquidity position is assessed as medium, wit…
The company's capital structure is characterized by a debt-to-equity ratio of 0.62, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
The company's capital structure is characterized by a high debt-to-equity ratio of 1.56, indicating a significant reliance on debt financing. The liquidity position is further strained by a current…
Peptron Inc's capital structure is characterized by a debt-to-equity ratio of 0.21, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a cur…
MITech Co Ltd maintains a strong liquidity position, with a current ratio of 9.65 and cash and equivalents amounting to 19,964,226,330 KRW, indicating a robust ability to meet short-term obligation…
The company maintains a strong liquidity position, with a current ratio of 2.79, indicating that it has more than enough current assets to cover its current liabilities. Additionally, the company h…
The company maintains a strong liquidity position, with a current ratio of 9.15, indicating that it holds significantly more current assets than current liabilities. Its cash and equivalents amount…
The company's capital structure is characterized by a debt-to-equity ratio of 1.28, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
Excelsior Medical Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.23, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, wi…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage position. Its liquidity position is strong, with a current ratio of 27.41,…
Applied BioCode Corp maintains a strong liquidity position, with cash and equivalents amounting to 489.24 million TWD, representing 50.8% of total assets. The company's liquidity FPT score indicate…
The company maintains a strong liquidity position, with a current ratio of 5.4, indicating a robust ability to meet short-term obligations. The liquidity_fpt metric further supports this, showing a…
BF Biosciences Ltd maintains a debt-to-equity ratio of 0.94, indicating a relatively balanced capital structure with a moderate reliance on debt financing. The company's liquidity position is asses…
Generate Biomedicines maintains a conservative capital structure with minimal leverage, evidenced by a debt-to-equity ratio of 0.04 and long-term debt of $7.2 million against total equity of $195.9…
NDT Pharmaceuticals Inc has a highly leveraged capital structure, with total liabilities of $400.7 million and total equity of -$70.9 million, resulting in a negative debt-to-equity ratio of -5.42.…
Sarana Meditama Metropolitan Tbk PT has a liquidity position that is characterized by a current ratio of 0.9, indicating that its current liabilities exceed its current assets. The company's cash a…
Marocaine Ste de Therapeutique SA has a basic capital structure with 7,661,900 shares outstanding, both basic and diluted, indicating no dilution from stock options or convertible instruments. Howe…
Sharps Technology Inc has a market capitalization of $77.3 million and a price-to-book ratio of 11.27, indicating a premium valuation relative to its book value. The company has no long-term debt a…
Vistin Pharma maintains a strong liquidity position, with a current ratio of 2.58 and a liquidity risk score of low. The company's cash and equivalents amount to NOK 16.4 million, and it has a free…
Hainan Haiyao Co Ltd operates with a debt-to-equity ratio of 1.63, indicating a capital structure that is significantly leveraged. The company's liquidity position is assessed as medium, with a cur…
Vi sender deg én e-post når Handelsavisen lanseres. Ingen spam, ingen annen bruk.
Ved å registrere deg samtykker du til å motta ett enkelt varsel fra Handelsavisen på lanseringsdagen.